Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A-LIST What Matters Most Insights Series

NCT04466722 is registered in ClinicalTrials.gov with UsAgainstAlzheimer's as lead sponsor.

NCT NCT04466722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A-LIST What Matters Most Insights Series
Lead sponsor
UsAgainstAlzheimer's
Phase
Observational
Overall status
Unknown status
Start date
August 15, 2018
Completion date
December 31, 2023
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, mild cognitive impairment